When an illness is serious or a child dies, parents deserve to be told in a way that helps them cope with their grief. Here are guidelines, drawn from study findings and personal experience, for carrying out this difficult.
Neffy for patients with anaphylactic symptoms after oral food challenge
Thomas Casale, MD, discusses phase 3 data presented at the 2024 AAAAI Meeting in Washington DC, highlighting neffy's efficacy in pediatric patients at risk for anaphylaxis.
Food Insecurity and the Dangers of Infant Formula Dilution
Neffy pharmacokinetic profiles compared to epinephrine injections
Sarina Tanimoto, MD, MBA, breaks down a poster session regarding the pharmacokinetic profile of neffy, presented at the 2024 American Academy of Allergy, Asthma, & Immunology Annual Meeting in Washington DC from February 23 to February 26, 2024.
Demystifying Infant Formula
FDA grants Priority Review to pitolisant for pediatric narcolepsy patients
A Prescription Drug User Fee Act (PDUFA) target action date of June 21, 2024, has been set by the FDA.
Fostering healthy eating habits
Donna Hallas shares her perspectives on the most recent issue of Contemporary Pediatrics.
2 Commerce Drive Cranbury, NJ 08512